Market

Mankind Pharma signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India

Read more

Prioritised investments from pharma companies shaping competitive pipeline landscape of bronchiectasis: GlobalData

Read more

Emcure makes a premium of 31.5 per cent over IPO price

Read more

Novo Holdings co-leads £90 million Series A financing for Myricx Bio

Read more

Industry reports 76 deals worth $5B in June 2023: GlobalData

Read more

Submission of Nidlegy marketing authorisation application validated by EMA

Read more

Emcure Pharmaceuticals secures ₹582 crore from anchor investors

Read more

Amylyx looks to cover financial gap left by Relyvrio with avexitide deal, says GlobalData

Read more

Asthma inhaler price cap in US may help pharma companies to secure more loyal customer base: GlobalData

Read more

Ayurveda market anticipated to hit $25 bn with international exports, says Dr Manoj Nesari

Read more